SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-016179
Filing Date
2018-11-19
Accepted
2018-11-19 16:03:57
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_yewbiopharm.htm 10-Q 728083
2 CERTIFICATION f10q0918ex31-1_yewbio.htm EX-31.1 10813
3 CERTIFICATION f10q0918ex31-2_yewbio.htm EX-31.2 10039
4 CERTIFICATION f10q0918ex32_yewbio.htm EX-32 5019
  Complete submission text file 0001213900-18-016179.txt   4733603

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20180930.xml EX-101.INS 858826
6 XBRL SCHEMA FILE yewb-20180930.xsd EX-101.SCH 64368
7 XBRL CALCULATION FILE yewb-20180930_cal.xml EX-101.CAL 52189
8 XBRL DEFINITION FILE yewb-20180930_def.xml EX-101.DEF 177668
9 XBRL LABEL FILE yewb-20180930_lab.xml EX-101.LAB 512287
10 XBRL PRESENTATION FILE yewb-20180930_pre.xml EX-101.PRE 328437
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 181192522
SIC: 0100 Agricultural Production-Crops
Assistant Director 5